Lorusso, V <br/><br/>
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.  [electronic resource] 

 -  International journal of oncology  Jan 2000 
 - 149-54 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1019-6439 
<br/><br/><label>Standard No.: </label>10.3892/ijo.16.1.149  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bleomycin--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Humans<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Staging<br/>Prednisone--administration & dosage<br/>Survival Analysis<br/>Treatment Outcome<br/>Vincristine--administration & dosage